Evidence map›Paper›PMID 23952779›Full record

ArticleBiofouling2013

Aggregatibacter actinomycetemcomitans biofilm killing by a targeted ciprofloxacin prodrug.

Benjamin D Reeves, Mark Young, Paul A Grieco, Peter Suci

Open access · greenAbstract read
In one paragraph

Article in Biofouling, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Benjamin D ReevesDepartment of Chemistry & Biochemistry, Montana State University, Bozeman, MT, USA.
Mark Young
Paul A Grieco
Peter Suci
Montana State University · US

Funding

Small molecular weight targeted killing agents against a periodontal pathogenR21DE022882 · NIDCR · MONTANA STATE UNIVERSITY - BOZEMAN · PI YOUNG, MARK J · 2013 to 2014
$396k
Targeted combinatiorial therapy for treatment of periodontal diseaseR21DE019237 · NIDCR · MONTANA STATE UNIVERSITY - BOZEMAN · PI YOUNG, MARK J · 2009 to 2010
$392k
NIDCR NIH HHS 1R21DE019237-01A1NIDCR NIH HHS R21 DE019237NIDCR NIH HHS R21 DE022882
6 · The paper itself

Abstract

A pH-sensitive ciprofloxacin prodrug was synthesized and targeted against biofilms of the periodontal pathogen Aggregatibacter actinomycetemcomitans (Aa). The dose required to reduce the viability of a mature biofilm of Aa by ~80% was in the range of ng cm(-2) of colonized area (mean biofilm density 2.33 × 10(9) cells cm(-2)). A mathematical model was formulated that predicts the temporal change in the concentration of ciprofloxacin in the Aa biofilm as the drug is released and diffuses into the bulk medium. The predictions of the model were consistent with the extent of killing obtained. The results demonstrate the feasibility of the strategy to induce mortality, and together with the mathematical model, provide the basis for design of targeted antimicrobial prodrugs for the topical treatment of oral infections such as periodontitis. The targeted prodrug approach offers the possibility of optimizing the dose of available antimicrobials in order to kill a chosen pathogen while leaving the commensal microbiota relatively undisturbed.

Indexed as

Aggregatibacter actinomycetemcomitansAnti-Bacterial AgentsBiofilmsBiotinylationCiprofloxacinDose-Response Relationship, DrugMicroscopy, ConfocalModels, TheoreticalProdrugsAnti-Bacterial AgentsCiprofloxacinProdrugs

Identifiers

PMID23952779
PMCPMC3818142
OpenAlexW2075248282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.